Plus Therapeutics (PSTV) Misses Q3 EPS by 37c

Plus Therapeutics (NASDAQ: PSTV) reported Q3 EPS of ($0.37). Revenue for the quarter came in at $1.45 million.

For earnings history and earnings-related data on Plus Therapeutics (PSTV) click here.

You May Also Be Interested In

• UGI shares spike on reported KKR bid for the company
• KKR offered to buy UGI for $42.50 a share - WSJ
• Amazon: to grow Louisiana data center investment from $12 billion to $18 billion with a third data center campus